B Cell-Based Treatments in SLE: Past Experience and Current Directions-Reference-Cited by-同舟云学术

B Cell-Based Treatments in SLE: Past Experience and Current Directions

Published:2017-11-04 Issue:12 Volume:19 Page:
ISSN:1523-3774
Container-title:Current Rheumatology Reports
language:en
Short-container-title:Curr Rheumatol Rep

Author:

Liossis Stamatis-Nick C.,Staveri Chrysanthi

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/article/10.1007/s11926-017-0707-z/fulltext.html

Reference74 articles.

1. Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest. 1996;98(11):2549–57.

2. Rydén-Aulin M, Boumpas D, et al. Off-label use of rituximab for systemic lupus erythematosus in Europe. Lupus Sci Med. 2016;3(1):e000163. https://doi.org/10.1136/lupus-2016-000163 .

3. Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, et al. Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE)—results from a nationwide cohort in Germany (GRAID). Lupus. 2013;22(11):1142–9. https://doi.org/10.1177/0961203313503912 .

4. Iaccarino L, Bartoloni E, Carli L, et al. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry. Clin Exp Rheumatol. 2015;33(4):449–56.

5. Hickman RA, Hira-Kazal R, Yee CS, Toescu V, Gordon C. The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosus. Clin Rheumatol. 2015;34(2):263–71. https://doi.org/10.1007/s10067-014-2839-0 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA NEAT1 promotes IL-6 secretion in monocyte-derived dendritic cells via sponging miR-365a-3p in systemic lupus erythematosus;Epigenetics;2023-06-21

2. Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus;Frontiers in Immunology;2023-05-10

3. Lactoferrin is required for early B cell development in C57BL/6 mice;Journal of Hematology & Oncology;2021-04-07

4. What's New in the Treatment of Systemic Lupus Erythematosus;Frontiers in Medicine;2021-03-05

5. Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice;Frontiers in Genetics;2020-11-09